Cardiometabolic predictive factors for mortality in patients with SARS-CoV-2/COVID-19
Keywords:
COVID-19, SARS-CoV-2, cardiometabolic factors, predictive, mortalityAbstract
Introduction: ending 2019, the first reported cases of Covid-19 broke out in Wuhan, China. This disease may affect directly the cardiovascular system or predispose it to be infected by the SARS-CoV-2.
Objective: to identify the cardiometabolic predictive factors for mortality in patients with SARS-CoV-2/COVID-19 from Santiago de Cuba city in the period May 2020 throughout May 2021.
Method: an analytical cohort study was carried out. It was a co-operative research that involved professionals from the Internal Medicine and Intensive Care Services at the Hospital Clínico Quirúrgico “Ambrosio Grillo Portuondo”, as well as professionals from the Dirección Municipal de Salud in Santiago de Cuba city. A sample of 120 patients was selected for the identification of cardiometabolic predictive factors for mortality. Data analysis was based on the performance of a multivariate model (multivariate logistic regression).
Results: throughout the hospitalization period 15 diseases were reported. Female sex was predominant but statistically we can´t associate to the deaths these two gender variables. However, age over 60 years, the arterial hypertension, diabetes mellitus and, in a high rank, the vascular involvement, were observed in a strongly association with mortality (p=0.0001).
Conclusions: this research allowed the identification of cardiometabolic predictive factors for mortality in COVID-19, where age over 60 years, vascular involvement (cardiogenic shock), hypertension and diabetes mellitus are the main causal factors in the pathophysiological and statistical explanation of mortality.
Downloads
References
2- Organización Mundial de la Salud. Rolling updates on coronavirus disease (COVID-19) Rolling updates on coronavirus disease (COVID-19). Visto el 19 de junio del 2021. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2 019/events-as-they-happen
3- Peretto, G., Sala, S., Rizzo, S., De Luca, G., Campochiaro, C., Sartorelli, S.,... & Thiene, G. (2019). Arrhythmias in myocarditis: state of the art. Heart rhythm, 16(5), 793-801.
4- 42. Peretto, G., Sala, S., Rizzo, S., Palmisano, A., Esposito, A., De Cobelli, F., ... & Thiene, G. (2020). Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation. Journal of the American College of Cardiology, 75(9), 1046-1057.
5- Comorbilidades y COVID-19 en Cuba: el desafío de las enfermedades asociadas. Disponible en: http://www.acn.cu/salud/76429-comorbilidades-y-covid-19-en-cuba-el-desafio-de-las-enfermedades-asociadas
6- Lo afirman los expertos: Pronósticos de la COVID-19 en Cuba son desfavorables. Disponible en: http://www.cubadebate.cu/noticias/2021/04/27/lo-afirman-los-expertos-pronosticos-de-la-covid-19-en-cuba-son-desfavorables/
7- Bandera Jiménez Digna de la C., Morandeira Padrón Hilda, Valdés García Luis E., Rodríguez Valdés Adriana, Sagaró del Campo Nelsa, Palú Orozco 13- 13- Adrián et al. Morbilidad por COVID-19: análisis de los aspectos epidemiológicos, clínicos y diagnósticos. Rev Cubana Med Trop [Internet]. 2020 Dic [citado 2021 Jun 19]; 72(3): e574. Disponible en: http://scielo.sld.cu/scielo.php?script=sciarttext&pid=S0375-0760 2020000300005&lng=es.
8- Ante la COVID-19 Santiago de Cuba no se puede cansar. Disponible en: http://www.granma.cu/cuba-covid-19/2021-06-18/hace-falta-exigencia-hace-falta-rigo r-en-santiago-de-cuba-frente-a-la-pandemia-18-06-2021-00-06-04.
9- González Tabares Rubén, Acosta González Frank Abel, Oliva Villa Evián, Rodríguez Reyes Sandy Fidel, Cabeza Echevarría Ivelyse. Predictores de mal pronóstico en pacientes con la COVID-19. Rev Cub Med Mil [Internet]. 2020 Dic [citado 2021 Jun 21]; 49(4): e918. Disponible en: http://scielo.sld.cu/scielo.php?scri pt=sciarttext&pid=S0138-65572020000400020&lng=es.
10- Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020; 323(20):2052?9. https://doi.org/10.1001/jama.2020.6775.
11- Zapata - Mercado JA, Gallegos - Pérez IA, Zapata - Mercado CI. Una revisión sobre factores clínicos y pronóstico en pacientes con diabetes mellitus infecta¬dos por el SARS-CoV-2. 16 de Abril [Internet]. 2020 [fecha de citación]; 59 (278): e1015. Disponible en: http://www.rev16deabril.sld.cu/index.php/16_4/article/view/1015
12- COVID-19, hipertensión y enfermedad cardiovascular. Disponible en: https://ww w.elsevier.es/es-revista-hipertension-riesgo-vascular-67-pdf-S18891 83720300659
13- Plasencia-Urizarri Thais M., Aguilera-Rodríguez Raúl, Almaguer-Mederos Luis E. Comorbilidades y gravedad clínica de la COVID-19: revisión sistemática y meta-análisis. Rev haban cienc méd [Internet]. 2020 [citado 2021 Jun 21]; 19(Suppl 1): e3389. Disponible en: http://scielo.sld.cu/scielo.php?script=sciarttext&pid=S1729-519 X2020000400002&lng=es.
14- Franco VD, Morales Chorro L, Baltrons Orellana R, Rodríguez Salmerón CR, Urbina O, López de Blanco C. Mortalidad por COVID-19 asociada a comorbilidades en pacientes del Instituto Salvadoreño del Seguro Social. Alerta. 2021;4(2): DOI:10.5377/alerta.v4i2.10366.
15- Barron E, Bakhai C, Kar P, Weaver A, Bradley D, Ismail H, et al. Associa¬tions of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endo [Internet] 2020 [citado 20 de septiembre 2020]; 8 (10): 813-22. Disponible en: https://www.thelancet.com/journals/landia/articl e/PIIS2213-8587(20)30272-2/fulltext
16- Liu Z, Li J, Huang J, Guo L, Gao R, Luo K, et al. Association Between Diabetes and COVID-19: A Retros¬pective Observational Study With a Large Sample of 1,880 Cases in Lei¬shenshan Hospital, Wuhan. Front Endocrinol [Internet] 2020 [citado 20 de septiembre 2020]; 11:478. Disponible en: https://www.fron¬tiersin.org/articles/10.3389 /fen¬do.2020.00478/full
17- Pettit, N. N., MacKenzie, E. L., Ridgway, J. P., Pursell, K., Ash, D., Patel, B., & Pho, M. T. (25 de Agosto de 2020). La obesidad se asocia con un mayor riesgo de mortalidad entre los pacientes hospitalizados con COVID-19. Obesity, 28(10), 1806-1810. doi:10.1002/oby.22941 https://www.google.com/search?client=firefox-b-
18- Yang, J., Hu, J., & Zhu, C. (26 de Junio de 2020). La obesidad agrava el COVID-19: una revisión siste-mática y un metaanálisis. J Med Virol, 93, 257-268. doi:10.1002/jmv.26237.
19- Miocarditis fulminante y shock cardiogénico en el curso de infección por SARS-CoV-2. Disponible en: https://www.elsevier.es/es-revista-medicina-clinica-2-pdf-S0025775 32030 52 61
